Alopecia areata in children: an overview of clinical features and recent treatment options

Alopecia areata is a chronic relapsing autoimmune disease characterized by local or diffuse non-scarring hair loss. Statistically, 0.2% of people worldwide are affected alopecia and 1.7% were diagnosed with it at some point in life. The incidence children has been rapidly increasing recent years.
 main role pathogenesis belongs to the loss immune privilege due influence genetics various external factors. Follicles become vulnerable attack patients own T-lymphocytes, which results shedding. Some allergic diseases known be comorbidities areata.
 diagnosis made on basis trichoscopy results, besides there manifestation features different than adults.
 Currently, several promising drugs but number studies (regarding pediatric patients) extremely limited. According authors, corticosteroids Janus kinase inhibitors have shown their effectiveness safety treatment childhood areata, although they not approved United States Food Drug Administration (FDA) moment.